Breaking News Instant updates and real-time market news.

CBL

CBL & Associates

$2.10

-0.2 (-8.71%)

08:09
12/19/18
12/19
08:09
12/19/18
08:09

CBL & Associates downgraded to Underweight from Neutral at JPMorgan

JPMorgan analyst Anthony Paolone downgraded CBL & Associates to Underweight. In addition to moving to a less constructive stance on the mall REITs as a group, the analyst believes that CBL's earnings growth will continue to be impacted in the near term by the carryover of headwinds from recent bankruptcies, rent reductions, and co-tenancy issues.

  • 08

    Feb

CBL CBL & Associates
$2.10

-0.2 (-8.71%)

08/07/18
BTIG
08/07/18
DOWNGRADE
Target $2.5
BTIG
Sell
CBL & Associates downgraded to Sell from Neutral at BTIG
BTIG analyst James Sullivan downgraded CBL & Associates to Sell from Neutral with a price target of $2.50 after the company warned in its earnings call that a dividend cut in FY19 is possible. The analyst cites the REIT's declining same-store net operating income, capital needs of its portfolio, and a high debt load while re-negotiating its bank lines ahead of a maturing term loan facility next year. Sullivan adds that while CBL's guidance implies some improvement in the second half of this year, its "weaker sales productivity" suggests that the rebound will be more shallow than that of its peers, anticipating a dividend cut of 30%-50%.
12/21/17
JEFF
12/21/17
DOWNGRADE
Target $4
JEFF
Underperform
CBL & Associates downgraded to Underperform from Hold at Jefferies
Jefferies analyst Omotayo Okusanya downgraded CBL & Associates to Underperform saying the shares will "remain impaired" in 2018 as the retail environment remains challenged. The analyst cut his price target for the shares to $4 from $5.
12/21/17
JEFF
12/21/17
DOWNGRADE
JEFF
Underperform
CBL & Associates downgraded to Underperform from Hold at Jefferies
12/20/17
RAJA
12/20/17
DOWNGRADE
RAJA
Underperform
CBL & Associates downgraded to Underperform at Raymond James
Raymond James analyst Collin Mings downgraded CBL & Associates to Underperform from Market Perform saying 2018 consensus estimates need to be reset lower, the company is disproportionately impacted by shifting consumer preferences, and capital allocation priorities will be difficult to balance. Mings expects results to be pressured for the foreseeable future from to occupancy pressure, leasing spreads and NOI.

TODAY'S FREE FLY STORIES

VZ

Verizon

$61.05

0.64 (1.06%)

07:20
10/21/19
10/21
07:20
10/21/19
07:20
Periodicals
Verizon seeking buyer for HuffPost website, FT reports »

Verizon is seeking a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 25

    Oct

  • 26

    Oct

  • 19

    Nov

  • 09

    Dec

URGN

UroGen Pharma

$22.34

0.06 (0.27%)

07:20
10/21/19
10/21
07:20
10/21/19
07:20
Recommendations
UroGen Pharma analyst commentary  »

UroGen Pharma recent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:20
10/21/19
10/21
07:20
10/21/19
07:20
General news
Treasury Market Outlook: yields are modestly higher as stocks rally »

Treasury Market Outlook:…

VLRX

Valeritas

$1.33

(0.00%)

07:18
10/21/19
10/21
07:18
10/21/19
07:18
Hot Stocks
Valeritas reports results from study on infusion of GLP-1 analogue with h-Patch »

Valeritas Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOMX

Foamix

$3.16

-0.08 (-2.47%)

07:17
10/21/19
10/21
07:17
10/21/19
07:17
Recommendations
Foamix analyst commentary  »

Foamix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$344.09

-25.04 (-6.78%)

07:17
10/21/19
10/21
07:17
10/21/19
07:17
Recommendations
Boeing analyst commentary  »

Boeing price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

MNTA

Momenta

$14.43

0.3 (2.12%)

07:17
10/21/19
10/21
07:17
10/21/19
07:17
Conference/Events
Momenta management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 31

    Oct

  • 07

    Dec

HSIC

Henry Schein

$62.79

-0.72 (-1.13%)

07:16
10/21/19
10/21
07:16
10/21/19
07:16
Hot Stocks
Henry Schein to be dismissed from Summit County opioid litigation »

Henry Schein announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 12

    Dec

MYGN

Myriad Genetics

$30.56

0.24 (0.79%)

07:16
10/21/19
10/21
07:16
10/21/19
07:16
Hot Stocks
Myriad Genetics appoints Mark Pollack as CMO of Myriad Neuroscience »

Myriad Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 13

    Nov

ATGE

Adtalem Global Education

$35.89

-0.37 (-1.02%)

07:16
10/21/19
10/21
07:16
10/21/19
07:16
Hot Stocks
Adtalem Global Education to sell Adtalem Educacional do Brasil to YDUQS »

Adtalem Global Education…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 13

    Nov

  • 14

    Nov

NVR

NVR

$3,890.80

121.94 (3.24%)

07:16
10/21/19
10/21
07:16
10/21/19
07:16
Recommendations
NVR analyst commentary  »

NVR price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

$64.47

-2.25 (-3.37%)

07:15
10/21/19
10/21
07:15
10/21/19
07:15
Downgrade
EOG Resources rating change  »

EOG Resources downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

VZ

Verizon

$61.05

0.64 (1.06%)

07:13
10/21/19
10/21
07:13
10/21/19
07:13
Hot Stocks
Verizon to deploy 5G home internet in Chicago »

Starting October 24,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 25

    Oct

  • 26

    Oct

  • 19

    Nov

  • 09

    Dec

PEP

PepsiCo

$136.25

-0.74 (-0.54%)

, KDP

Keurig Dr Pepper

$27.58

-0.01 (-0.04%)

07:12
10/21/19
10/21
07:12
10/21/19
07:12
Recommendations
PepsiCo, Keurig Dr Pepper analyst commentary  »

Morgan Stanley suggests…

PEP

PepsiCo

$136.25

-0.74 (-0.54%)

KDP

Keurig Dr Pepper

$27.58

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

LNDC

Landec

$9.41

0.14 (1.51%)

07:11
10/21/19
10/21
07:11
10/21/19
07:11
Conference/Events
Landec management to meet with Maxim »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 28

    Oct

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

LAC

Lithium Americas

$3.02

0.04 (1.34%)

07:09
10/21/19
10/21
07:09
10/21/19
07:09
Hot Stocks
Lithium Americas appoints Yuan Gao to board of directors »

Lithium Americas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARQL

ArQule

$9.13

-0.17 (-1.83%)

07:08
10/21/19
10/21
07:08
10/21/19
07:08
Hot Stocks
ArQule announces preclinical data showing potential for miransertib to treat VMs »

ArQule announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 30

    Oct

SON

Sonoco

$58.07

0.85 (1.49%)

07:08
10/21/19
10/21
07:08
10/21/19
07:08
Upgrade
Sonoco rating change  »

Sonoco upgraded to Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$130.91

-1.46 (-1.10%)

07:08
10/21/19
10/21
07:08
10/21/19
07:08
Conference/Events
Disney management to meet with Oppenheimer »

Luncheon Meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 07

    Nov

IDRA

Idera Pharmaceuticals

$2.68

-0.01 (-0.37%)

07:07
10/21/19
10/21
07:07
10/21/19
07:07
Hot Stocks
Idera Pharmaceuticals annnounces U.S. patent for tilsotolimod »

Idera Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBI

Brickell Biotech

$4.10

-0.08 (-1.91%)

07:06
10/21/19
10/21
07:06
10/21/19
07:06
Conference/Events
Brickell Biotech management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

SEAS

SeaWorld

$27.88

0.23 (0.83%)

07:06
10/21/19
10/21
07:06
10/21/19
07:06
Hot Stocks
SeaWorld to open second Sesame Place theme park in San Diego in 2021 »

SeaWorld and Sesame…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARMP

Armata Pharmaceuticals

$4.10

0.05 (1.23%)

07:06
10/21/19
10/21
07:06
10/21/19
07:06
Hot Stocks
Armata Pharmaceuticals announces receipt of $1.3M R&D Tax Incentive »

Armata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGTC

Applied Genetic

$3.05

-0.06 (-1.93%)

07:06
10/21/19
10/21
07:06
10/21/19
07:06
Hot Stocks
Applied Genetic presents data from non-clinical studies evaluating AAV vectors »

Applied Genetic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$236.29

0.99 (0.42%)

07:05
10/21/19
10/21
07:05
10/21/19
07:05
Recommendations
Apple analyst commentary  »

iPhone Pro lead times…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.